223 related articles for article (PubMed ID: 19471318)
1. A novel microdeletion syndrome involving 5q14.3-q15: clinical and molecular cytogenetic characterization of three patients.
Engels H; Wohlleber E; Zink A; Hoyer J; Ludwig KU; Brockschmidt FF; Wieczorek D; Moog U; Hellmann-Mersch B; Weber RG; Willatt L; Kreiss-Nachtsheim M; Firth HV; Rauch A
Eur J Hum Genet; 2009 Dec; 17(12):1592-9. PubMed ID: 19471318
[TBL] [Abstract][Full Text] [Related]
2. [Infantile spasm associated with 5q14.3 microdeletion syndrome: clinical and genetic characterization of a core family].
Yu D; Li S; Jiang N
Zhonghua Er Ke Za Zhi; 2015 Feb; 53(2):140-2. PubMed ID: 25876691
[TBL] [Abstract][Full Text] [Related]
3. Microdeletion at chromosome 4q21 defines a new emerging syndrome with marked growth restriction, mental retardation and absent or severely delayed speech.
Bonnet C; Andrieux J; Béri-Dexheimer M; Leheup B; Boute O; Manouvrier S; Delobel B; Copin H; Receveur A; Mathieu M; Thiriez G; Le Caignec C; David A; de Blois MC; Malan V; Philippe A; Cormier-Daire V; Colleaux L; Flori E; Dollfus H; Pelletier V; Thauvin-Robinet C; Masurel-Paulet A; Faivre L; Tardieu M; Bahi-Buisson N; Callier P; Mugneret F; Edery P; Jonveaux P; Sanlaville D
J Med Genet; 2010 Jun; 47(6):377-84. PubMed ID: 20522426
[TBL] [Abstract][Full Text] [Related]
4. Mutations in MEF2C from the 5q14.3q15 microdeletion syndrome region are a frequent cause of severe mental retardation and diminish MECP2 and CDKL5 expression.
Zweier M; Gregor A; Zweier C; Engels H; Sticht H; Wohlleber E; Bijlsma EK; Holder SE; Zenker M; Rossier E; Grasshoff U; Johnson DS; Robertson L; Firth HV; ; Ekici AB; Reis A; Rauch A
Hum Mutat; 2010 Jun; 31(6):722-33. PubMed ID: 20513142
[TBL] [Abstract][Full Text] [Related]
5. MEF2C haploinsufficiency caused by either microdeletion of the 5q14.3 region or mutation is responsible for severe mental retardation with stereotypic movements, epilepsy and/or cerebral malformations.
Le Meur N; Holder-Espinasse M; Jaillard S; Goldenberg A; Joriot S; Amati-Bonneau P; Guichet A; Barth M; Charollais A; Journel H; Auvin S; Boucher C; Kerckaert JP; David V; Manouvrier-Hanu S; Saugier-Veber P; Frébourg T; Dubourg C; Andrieux J; Bonneau D
J Med Genet; 2010 Jan; 47(1):22-9. PubMed ID: 19592390
[TBL] [Abstract][Full Text] [Related]
6. 2q23.1 microdeletion identified by array comparative genomic hybridisation: an emerging phenotype with Angelman-like features?
Jaillard S; Dubourg C; Gérard-Blanluet M; Delahaye A; Pasquier L; Dupont C; Henry C; Tabet AC; Lucas J; Aboura A; David V; Benzacken B; Odent S; Pipiras E
J Med Genet; 2009 Dec; 46(12):847-55. PubMed ID: 18812405
[TBL] [Abstract][Full Text] [Related]
7. Novel interstitial 2q12.3q13 microdeletion predisposes to developmental delay and behavioral problems.
Huynh MT; Gérard M; Ranguin K; Pichon O; Ghesh L; Alfallaj K; Joubert M; Bézieau S; Bénéteau C
Neurogenetics; 2021 Jul; 22(3):195-206. PubMed ID: 34132911
[TBL] [Abstract][Full Text] [Related]
8. Interstitial deletion 5q14.3q21.3 with MEF2C haploinsufficiency and mild phenotype: when more is less.
Tonk V; Kyhm JH; Gibson CE; Wilson GN
Am J Med Genet A; 2011 Jun; 155A(6):1437-41. PubMed ID: 21567930
[TBL] [Abstract][Full Text] [Related]
9. Interstitial deletion of the long arm of chromosome 5 in a boy with multiple congenital anomalies and mental retardation: Molecular characterization of the deleted region to 5q22.3q23.3.
Garcia-Miñaur S; Ramsay J; Grace E; Minns RA; Myles LM; FitzPatrick DR
Am J Med Genet A; 2005 Feb; 132A(4):402-10. PubMed ID: 15742475
[TBL] [Abstract][Full Text] [Related]
10. Clinical and molecular cytogenetic characterisation of a newly recognised microdeletion syndrome involving 2p15-16.1.
Rajcan-Separovic E; Harvard C; Liu X; McGillivray B; Hall JG; Qiao Y; Hurlburt J; Hildebrand J; Mickelson EC; Holden JJ; Lewis ME
J Med Genet; 2007 Apr; 44(4):269-76. PubMed ID: 16963482
[TBL] [Abstract][Full Text] [Related]
11. 13q Deletion and central nervous system anomalies: further insights from karyotype-phenotype analyses of 14 patients.
Ballarati L; Rossi E; Bonati MT; Gimelli S; Maraschio P; Finelli P; Giglio S; Lapi E; Bedeschi MF; Guerneri S; Arrigo G; Patricelli MG; Mattina T; Guzzardi O; Pecile V; Police A; Scarano G; Larizza L; Zuffardi O; Giardino D
J Med Genet; 2007 Jan; 44(1):e60. PubMed ID: 17209130
[TBL] [Abstract][Full Text] [Related]
12. Severe mental retardation, seizures, and hypotonia due to deletions of MEF2C.
Nowakowska BA; Obersztyn E; Szymańska K; Bekiesińska-Figatowska M; Xia Z; Ricks CB; Bocian E; Stockton DW; Szczałuba K; Nawara M; Patel A; Scott DA; Cheung SW; Bohan TP; Stankiewicz P
Am J Med Genet B Neuropsychiatr Genet; 2010 Jul; 153B(5):1042-51. PubMed ID: 20333642
[TBL] [Abstract][Full Text] [Related]
13. Microdeletion 5q14.3 and anomalies of brain development.
Hotz A; Hellenbroich Y; Sperner J; Linder-Lucht M; Tacke U; Walter C; Caliebe A; Nagel I; Saunders DE; Wolff G; Martin P; Morris-Rosendahl DJ
Am J Med Genet A; 2013 Sep; 161A(9):2124-33. PubMed ID: 23824879
[TBL] [Abstract][Full Text] [Related]
14. A 5q12.1-5q12.3 microdeletion in a case with a balanced exceptional complex chromosomal rearrangement.
Cetin Z; Yakut S; Clark OA; Mihci E; Berker S; Luleci G
Gene; 2013 Mar; 516(1):176-80. PubMed ID: 23262338
[TBL] [Abstract][Full Text] [Related]
15. ADGRV1 is implicated in myoclonic epilepsy.
Myers KA; Nasioulas S; Boys A; McMahon JM; Slater H; Lockhart P; Sart DD; Scheffer IE
Epilepsia; 2018 Feb; 59(2):381-388. PubMed ID: 29266188
[TBL] [Abstract][Full Text] [Related]
16. Periventricular heterotopia, mental retardation, and epilepsy associated with 5q14.3-q15 deletion.
Cardoso C; Boys A; Parrini E; Mignon-Ravix C; McMahon JM; Khantane S; Bertini E; Pallesi E; Missirian C; Zuffardi O; Novara F; Villard L; Giglio S; Chabrol B; Slater HR; Moncla A; Scheffer IE; Guerrini R
Neurology; 2009 Mar; 72(9):784-92. PubMed ID: 19073947
[TBL] [Abstract][Full Text] [Related]
17. Interstitial deletion of 5q33.3q35.1 in a girl with mild mental retardation.
Spranger S; Rommel B; Jauch A; Bodammer R; Mehl B; Bullerdiek J
Am J Med Genet; 2000 Jul; 93(2):107-9. PubMed ID: 10869111
[TBL] [Abstract][Full Text] [Related]
18. Molecular cytogenetic analysis of a de novo interstitial deletion of 5q23.3q31.2 and its phenotypic consequences.
Tzschach A; Krause-Plonka I; Menzel C; Kalscheuer V; Toennies H; Scherthan H; Knoblauch A; Radke M; Ropers HH; Hoeltzenbein M
Am J Med Genet A; 2006 Mar; 140(5):496-502. PubMed ID: 16470790
[TBL] [Abstract][Full Text] [Related]
19. The discovery of microdeletion syndromes in the post-genomic era: review of the methodology and characterization of a new 1q41q42 microdeletion syndrome.
Shaffer LG; Theisen A; Bejjani BA; Ballif BC; Aylsworth AS; Lim C; McDonald M; Ellison JW; Kostiner D; Saitta S; Shaikh T
Genet Med; 2007 Sep; 9(9):607-16. PubMed ID: 17873649
[TBL] [Abstract][Full Text] [Related]
20. Interstitial deletion 5q14.3q21.3 associated with lethal epilepsy.
Yang YJ; Yao X; Guo J; Zhao R; He XY; Zhao L; Tu M; Zhu YM
Am J Med Genet A; 2015 Apr; 167A(4):866-71. PubMed ID: 25706510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
